NCT01962805View on ClinicalTrials.gov

Comparison of Two Formulations of Proellex for Vaginal Administration

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Comparison of 2 Different Formulations of 12 mg Proellex Vaginal Capsules
Interventions
DRUG

Proellex Formulation A

DRUG

Proellex Formulation B

Trial Locations (1)

77030

Houston

All Listed Sponsors
lead

Repros Therapeutics Inc.

INDUSTRY

NCT01962805 - Comparison of Two Formulations of Proellex for Vaginal Administration | Biotech Hunter | Biotech Hunter